4
Changes in Ownership
ARS Pharmaceuticals, Inc. Filed Acc 0002149973-26-000004
Options or other derivatives
- Chief Commercial Officer acquired 1,001,738 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Smith Margaret Ekins Chief Commercial Officer | 2026-09-01 | Grant or award · Stock Option (right to buy) | +1,001,738 | 1,001,738 | D | ||
Loading xslF345X06/form4-09022026_090920.xml…